Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part I: sensitization & dose toxicity

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11690%2F14%3A10293371" target="_blank" >RIV/00216208:11690/14:10293371 - isvavai.cz</a>
Result on the web
<a href="http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoiding_adverse_health_outcomes_1_en.pdf" target="_blank" >http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoiding_adverse_health_outcomes_1_en.pdf</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part I: sensitization & dose toxicity
Original language description
The primary objective of this stated-preference study was to estimate willingness to pay to avoid selected adverse human health outcomes due to exposure to chemicals in the European Union and to derive representative EU-wide benefit estimates reference values. The results are intended for use by ECHA and other bodies when carrying out socio-economic analyses or health impact assessments in connection to REACH Regulation. The study focused on health outcomes related to two key toxicological endpoints: (1) sensitization, (2) dose toxicity. Each health outcome that is valued in this study was selected based on a comprehensive literature review, consultations with epidemiologists and medical experts and in close cooperation with ECHA.
Czech name
—
Czech description
—

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)